Dr. August Wolff GmbH & Co. KG Arzneimittel   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Bielefeld Germany (1911)

Organization Overview

First Clinical Trial
2003
NCT00204269
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Dr. August Wolff GmbH & Co. KG Arzneimittel

Active Ingredients

Drugs in Phase 4 Trials (5)

chlorhexidine (hibitane) (1 trial)

doxycycline (vibramycin) (1 trial)

edetic acid (1 trial)

estriol (1 trial)

ibuprofen (motrin) (1 trial)

Drugs in Phase 3 Trials (2)

glycopyrronium (robinul) (4 trials)

testosterone (delatestryl) (1 trial)

Drugs in Phase 2 Trials (1)

lactic acid (1 trial)

Drugs in Phase 1 Trials (1)

wol071-007 (1 trial)

Drugs in Other Trials (1)

wo 4260 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 4)

Dermatitis (Phase 1)

Dermatitis, Atopic (Phase 1)

Hyperhidrosis (Phase 3)

Hypogonadism (Phase 3)

Periodontitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 10